{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:49:10Z","timestamp":1777013350489,"version":"3.51.4"},"reference-count":99,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":387,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jtct.2022.01.027","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T12:19:48Z","timestamp":1643977188000},"page":"249.e1-249.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Thrombospondin-1, Platelet Factor 4, and Galectin-1 Are Associated with Engraftment in Patients with Sickle Cell Disease who Underwent Haploidentical Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7001-4200","authenticated-orcid":false,"given":"Ahmad","family":"Shaikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purevdorj B.","family":"Olkhanud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arunakumar","family":"Gangaplara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdoul","family":"Kone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajni","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7890-2520","authenticated-orcid":false,"given":"Marjan","family":"Gucek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5306-7167","authenticated-orcid":false,"given":"Courtney D.","family":"Fitzhugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2022.01.027_bib0001","doi-asserted-by":"crossref","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jtct.2022.01.027_bib0002","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1517\/14740338.2015.1088827","article-title":"Hydroxyurea therapy for sickle cell anemia","volume":"14","author":"McGann","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jtct.2022.01.027_bib0003","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2022.01.027_bib0004","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2022.01.027_bib0005","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2016-10-745711","article-title":"Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation","volume":"129","author":"Gluckman","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.01.027_bib0006","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.bmt.1703887","article-title":"Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies","volume":"31","author":"Krishnamurti","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.027_bib0007","first-page":"27","article-title":"Availability of related donors for bone marrow transplantation in sickle cell anemia","volume":"16","author":"Mentzer","year":"1994","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0008","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1182\/blood-2017-03-772392","article-title":"At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT","volume":"130","author":"Fitzhugh","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.01.027_bib0009","first-page":"100","article-title":"Barriers to bone marrow transplantation for sickle cell anemia","volume":"2","author":"Walters","year":"1996","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.027_bib0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbmt.2015.10.017","article-title":"Indications and results of HLA-identical sibling hematopoietic cell transplantation for sickle cell disease","volume":"22","author":"Walters","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.027_bib0011","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1182\/blood-2012-07-438408","article-title":"HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease","volume":"120","author":"Bola\u00f1os-Meade","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.01.027_bib0012","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1182\/bloodadvances.2016002972","article-title":"Cyclophosphamide improves engraftment in patients with SCD and severe organ damage who undergo haploidentical PBSCT","volume":"1","author":"Fitzhugh","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2022.01.027_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217163","article-title":"Standardisation of flow cytometry for whole blood immunophenotyping of islet transplant and transplant clinical trial recipients","volume":"14","author":"Jimenez Vera","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jtct.2022.01.027_bib0014","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4025073","article-title":"Donor specific anti-HLA antibody and risk of graft failure in haploidentical stem cell transplantation","volume":"2016","author":"Kongtim","year":"2016","journal-title":"Adv Hematol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0015","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1586\/eci.09.36","article-title":"Noninvasive methods to assess the risk of kidney transplant rejection","volume":"5","author":"Cravedi","year":"2009","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0016","volume":"3","author":"Moreau","year":"2013","journal-title":"Effector mechanisms of rejection. Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jtct.2022.01.027_bib0017","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrneph.2013.281","article-title":"Biomarkers for kidney transplant rejection","volume":"10","author":"Lo","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0018","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1586\/epr.11.66","article-title":"Recent advances in biomarker discovery in solid organ transplant by proteomics","volume":"8","author":"Sigdel","year":"2011","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.jtct.2022.01.027_bib0019","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri2568","article-title":"Towards the identification of biomarkers of transplantation tolerance","volume":"9","author":"Turka","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0020","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nature06916","article-title":"Mining the plasma proteome for cancer biomarkers","volume":"452","author":"Hanash","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jtct.2022.01.027_bib0021","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3389\/fphys.2017.01009","article-title":"Discovery of a potential plasma protein biomarker panel for acute-on-chronic liver failure induced by hepatitis B virus","volume":"8","author":"Zhou","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0022","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.bbmt.2013.06.011","article-title":"A novel soluble form of Tim-3 associated with severe graft-versus-host disease","volume":"19","author":"Hansen","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.027_bib0023","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.bbmt.2017.04.019","article-title":"Association of plasma CD163 concentration with de novo-onset chronic graft-versus-host disease","volume":"23","author":"Inamoto","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.027_bib0024","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood-2013-08-520072","article-title":"Plasma CXCL9 elevations correlate with chronic GVHD diagnosis","volume":"123","author":"Kitko","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.01.027_bib0025","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1182\/blood-2012-01-403063","article-title":"Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study","volume":"119","author":"Levine","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.01.027_bib0026","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000406","article-title":"Elafin is a biomarker of graft-versus-host disease of the skin","volume":"2","author":"Paczesny","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtct.2022.01.027_bib0027","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood-2008-07-167098","article-title":"A biomarker panel for acute graft-versus-host disease","volume":"113","author":"Paczesny","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.01.027_bib0028","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMoa1213299","article-title":"ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death","volume":"369","author":"Vander Lugt","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2022.01.027_bib0029","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1200\/JCO.2015.65.9615","article-title":"Biomarker panel for chronic graft-versus-host disease","volume":"34","author":"Yu","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13020-017-0160-y","article-title":"iTRAQ-based proteomic analysis to identify the molecular mechanism of Zhibai Dihuang Granule in the Yin-deficiency-heat syndrome rats","volume":"13","author":"Liu","year":"2018","journal-title":"Chin Med"},{"key":"10.1016\/j.jtct.2022.01.027_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170741","article-title":"iTRAQ-based proteomics reveals novel biomarkers for idiopathic pulmonary fibrosis","volume":"12","author":"Niu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jtct.2022.01.027_bib0032","doi-asserted-by":"crossref","first-page":"28042","DOI":"10.1038\/srep28042","article-title":"Plasma proteomic analysis of stable coronary artery disease indicates impairment of reverse cholesterol pathway","volume":"6","author":"Basak","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtct.2022.01.027_bib0033","article-title":"iTRAQ-based proteomic analysis reveals protein profile in plasma from children with autism","volume":"12","author":"Shen","year":"2018","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.jtct.2022.01.027_bib0034","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.bmt.1703162","article-title":"Standardisation of multiplex fluorescent short tandem repeat analysis for chimerism testing","volume":"28","author":"Nollet","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.01.027_bib0035","first-page":"1282","article-title":"[Evaluation of hematopoietic chimerism after allogeneic bone marrow transplantation by modern molecular techniques (STR-PCR and RQ-PCR)\u2013single center]","volume":"67","author":"Czekalska","year":"2010","journal-title":"Przegl Lek"},{"key":"10.1016\/j.jtct.2022.01.027_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.757279","article-title":"Early myeloid derived suppressor cells (eMDSCs) are associated with high donor myeloid chimerism following haploidentical HSCT for sickle cell disease","author":"Bhat","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0037","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1600-065X.2009.00787.x","article-title":"Conveying glycan information into T-cell homeostatic programs: a challenging role for galectin-1 in inflammatory and tumor microenvironments","volume":"230","author":"Rabinovich","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jtct.2022.01.027_bib0038","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.clim.2003.08.003","article-title":"Amelioration of graft versus host disease by galectin-1","volume":"109","author":"Baum","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0039","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/378736a0","article-title":"Apoptosis of T cells mediated by galectin-1","volume":"378","author":"Perillo","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.jtct.2022.01.027_bib0040","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.intimp.2010.03.001","article-title":"Immunological tolerance induced by galectin-1 in rat allogeneic renal transplantation","volume":"10","author":"Xu","year":"2010","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0041","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/intimm\/dxl060","article-title":"Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis","volume":"18","author":"Sugimoto","year":"2006","journal-title":"Int Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0042","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1182\/blood-2006-04-016451","article-title":"Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells","volume":"109","author":"Garin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.01.027_bib0043","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2311::AID-IMMU2311>3.0.CO;2-G","article-title":"Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells","volume":"28","author":"Blaser","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0044","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/B:MCBI.0000049376.50242.7f","article-title":"Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1\/ERK, p38 MAP kinase and p70S6 kinase","volume":"267","author":"Fuertes","year":"2004","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jtct.2022.01.027_bib0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/jlb.59.3.363","article-title":"Regulated expression of a 16-kD galectin-like protein in activated rat macrophages","volume":"59","author":"Rabinovich","year":"1996","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0046","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/sj.cdd.4401009","article-title":"Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-apoptotic mechanisms","volume":"9","author":"Rabinovich","year":"2002","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jtct.2022.01.027_bib0047","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1189\/jlb.70.1.73","article-title":"Regulated expression of galectin-1 during B-cell activation and implications for T-cell apoptosis","volume":"70","author":"Zu\u00f1iga","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0048","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.4049\/jimmunol.163.7.3801","article-title":"Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1","volume":"163","author":"Pace","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0049","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nri2536","article-title":"Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation","volume":"9","author":"Rabinovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0050","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/glycob\/cwl037","article-title":"Effects of N-glycan processing inhibitors on signaling events and induction of apoptosis in galectin-1-stimulated Jurkat T lymphocytes","volume":"16","author":"Walzel","year":"2006","journal-title":"Glycobiology"},{"key":"10.1016\/j.jtct.2022.01.027_bib0051","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/ni1482","article-title":"Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death","volume":"8","author":"Toscano","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0052","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.molimm.2006.02.011","article-title":"Strongly enhanced IL-10 production using stable galectin-1 homodimers","volume":"44","author":"van der Leij","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0053","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1038\/s41598-018-19965-z","article-title":"Galectin-1 is required for the regulatory function of B cells","volume":"8","author":"Alhabbab","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtct.2022.01.027_bib0054","doi-asserted-by":"crossref","first-page":"13134","DOI":"10.1073\/pnas.0706017104","article-title":"The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma","volume":"104","author":"Juszczynski","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtct.2022.01.027_bib0055","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.4049\/jimmunol.176.10.6323","article-title":"Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses","volume":"176","author":"Toscano","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0056","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nm1680","article-title":"A pivotal role for galectin-1 in fetomaternal tolerance","volume":"13","author":"Blois","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jtct.2022.01.027_bib0057","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1002\/eji.201142325","article-title":"Absence of galectin-1 accelerates CD8+ T cell-mediated graft rejection","volume":"42","author":"Moreau","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0058","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/ajt.12088","article-title":"Galectin-1 prolongs survival of mouse liver allografts from Flt3L-pretreated donors","volume":"13","author":"Ye","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jtct.2022.01.027_bib0059","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.transproceed.2014.12.001","article-title":"Galectin-1 in stable liver transplant recipients","volume":"47","author":"Garcia","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jtct.2022.01.027_bib0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0888-7543(90)90528-3","article-title":"Mapping of the thrombospondin gene to human chromosome 15 and mouse chromosome 2 by in situ hybridization","volume":"7","author":"Jaffe","year":"1990","journal-title":"Genomics"},{"key":"10.1016\/j.jtct.2022.01.027_bib0061","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.4049\/jimmunol.177.6.3534","article-title":"Thrombospondin\/CD47 interaction: a pathway to generate regulatory T cells from human CD4+CD25- T cells in response to inflammation","volume":"177","author":"Grimbert","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0062","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1046\/j.1523-1755.2002.00149.x","article-title":"Molecular and structural consequences of early renal allograft injury","volume":"61","author":"Baboolal","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.jtct.2022.01.027_bib0063","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/1523-1747.ep12461198","article-title":"Thrombospondin in early human wound tissue","volume":"89","author":"Raugi","year":"1987","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0064","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.4049\/jimmunol.1001133","article-title":"Thrombospondin-1 derived from APCs regulates their capacity for allosensitization","volume":"185","author":"Saban","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0065","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1038\/srep03345","article-title":"TSP1-producing B cells show immune regulatory property and suppress allergy-related mucosal inflammation","volume":"3","author":"Zhang","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtct.2022.01.027_bib0066","doi-asserted-by":"crossref","first-page":"12858","DOI":"10.1074\/jbc.M114.623421","article-title":"Thrombospondin-1 (TSP1)-producing B cells restore antigen (Ag)-specific immune tolerance in an allergic environment","volume":"290","author":"Yang","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtct.2022.01.027_bib0067","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/296069","article-title":"Thrombospondin-1: multiple paths to inflammation","volume":"2011","author":"Lopez-Dee","year":"2011","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jtct.2022.01.027_bib0068","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1172\/JCI12749","article-title":"Thrombospondins as matricellular modulators of cell function","volume":"107","author":"Bornstein","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2022.01.027_bib0069","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0092-8674(00)81460-9","article-title":"Thrombospondin-1 is a major activator of TGF-beta1 in vivo","volume":"93","author":"Crawford","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.jtct.2022.01.027_bib0070","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.4049\/jimmunol.166.4.2427","article-title":"Thrombospondin-1 inhibits TCR-mediated T lymphocyte early activation","volume":"166","author":"Li","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0071","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.4049\/jimmunol.165.8.4624","article-title":"CD47 ligation selectively inhibits the development of human naive T cells into Th1 effectors","volume":"165","author":"Avice","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0072","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.4049\/jimmunol.167.5.2547","article-title":"Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation","volume":"167","author":"Latour","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0073","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/9780470035399.ch9","article-title":"Linking innate to adaptive immunity through dendritic cells","volume":"279","author":"Steinman","year":"2006","journal-title":"Novartis Found Symp"},{"key":"10.1016\/j.jtct.2022.01.027_bib0074","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.4049\/jimmunol.164.4.2193","article-title":"CD47 engagement inhibits cytokine production and maturation of human dendritic cells","volume":"164","author":"Demeure","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0075","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1084\/jem.20030705","article-title":"Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation","volume":"198","author":"Doyen","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtct.2022.01.027_bib0076","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1038\/jid.2008.447","article-title":"The angiogenesis inhibitor thrombospondin-1 inhibits acute cutaneous hypersensitivity reactions","volume":"129","author":"Velasco","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0077","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ni.1607","article-title":"A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells","volume":"9","author":"Liu","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0078","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1084\/jem.20042276","article-title":"TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells","volume":"201","author":"Marie","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtct.2022.01.027_bib0079","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.biocel.2004.12.003","article-title":"Platelet factor 4: a chemokine enigma","volume":"37","author":"Slungaard","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0080","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1161\/01.CIR.89.4.1523","article-title":"Heparin neutralization by platelet-rich thrombi. Role of platelet factor 4","volume":"89","author":"Eitzman","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jtct.2022.01.027_bib0081","doi-asserted-by":"crossref","first-page":"e454","DOI":"10.1161\/01.CIR.0000147537.72829.1B","article-title":"Heparin-induced thrombocytopenia: diagnosis and management","volume":"110","author":"Warkentin","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jtct.2022.01.027_bib0082","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1182\/blood.V89.7.2328","article-title":"Platelet factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents","volume":"89","author":"Han","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.01.027_bib0083","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1365-2141.1995.tb05399.x","article-title":"Platelets prime PMN via released PF4: mechanism of priming and synergy with GM-CSF","volume":"91","author":"Aziz","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0084","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/jlb.58.5.575","article-title":"A novel biological effect of platelet factor 4 (PF4): enhancement of LPS-induced tissue factor activity in monocytes","volume":"58","author":"Engstad","year":"1995","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0085","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1189\/jlb.72.3.590","article-title":"Platelet factor 4 induces human natural killer cells to synthesize and release interleukin-8","volume":"72","author":"Marti","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0086","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1189\/jlb.0105024","article-title":"Regulated expression of platelet factor 4 in human monocytes\u2014role of PARs as a quantitatively important monocyte activation pathway","volume":"78","author":"Schaffner","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0087","doi-asserted-by":"crossref","first-page":"770","DOI":"10.4049\/jimmunol.169.2.770","article-title":"Platelet factor 4 inhibits proliferation and cytokine release of activated human T cells","volume":"169","author":"Fleischer","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0088","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.4049\/jimmunol.174.5.2680","article-title":"Platelet factor 4 differentially modulates CD4+CD25+ (regulatory) versus CD4+CD25- (nonregulatory) T cells","volume":"174","author":"Liu","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0089","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/sji.12257","article-title":"Platelet factor 4 limits Th17 differentiation and ischaemia-reperfusion injury after liver transplantation in mice","volume":"81","author":"Guo","year":"2015","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0090","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1172\/JCI71858","article-title":"Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection","volume":"124","author":"Shi","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2022.01.027_bib0091","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s10753-014-9958-2","article-title":"Platelet factor 4 protects kidney allograft in a rat kidney transplantation model","volume":"38","author":"Zhang","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.jtct.2022.01.027_bib0092","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jtct.2022.01.027_bib0093","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-065X.2007.00565.x","article-title":"'Yin-Yang' functions of transforming growth factor-beta and T regulatory cells in immune regulation","volume":"220","author":"Wan","year":"2007","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jtct.2022.01.027_bib0094","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2853","article-title":"TGFbeta signalling: a complex web in cancer progression","volume":"10","author":"Ikushima","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jtct.2022.01.027_bib0095","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.celrep.2015.09.070","article-title":"Transcriptomics identify CD9 as a marker of murine IL-10-competent regulatory B cells","volume":"13","author":"Sun","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.jtct.2022.01.027_bib0096","first-page":"487","article-title":"Interleukin 10 expression is correlated with thrombospondin expression and decreased vascular involvement in colon cancer","volume":"18","author":"Kawakami","year":"2001","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0097","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.4049\/jimmunol.1601165","article-title":"Talin plays a critical role in the maintenance of the regulatory T cell pool","volume":"198","author":"Klann","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0098","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.4049\/jimmunol.1700074","article-title":"The ERM protein moesin regulates CD8+ regulatory T cell homeostasis and self-tolerance","volume":"199","author":"Satooka","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2022.01.027_bib0099","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni.1772","article-title":"Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10","volume":"10","author":"Ilarregui","year":"2009","journal-title":"Nat Immunol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722000537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722000537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:02:20Z","timestamp":1763002940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636722000537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2666636722000537"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2022.01.027","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombospondin-1, Platelet Factor 4, and Galectin-1 Are Associated with Engraftment in Patients with Sickle Cell Disease who Underwent Haploidentical Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2022.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}